1. Home
  2. TVTX vs NUV Comparison

TVTX vs NUV Comparison

Compare TVTX & NUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • NUV
  • Stock Information
  • Founded
  • TVTX 2008
  • NUV 1987
  • Country
  • TVTX United States
  • NUV United States
  • Employees
  • TVTX N/A
  • NUV N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • NUV Trusts Except Educational Religious and Charitable
  • Sector
  • TVTX Health Care
  • NUV Finance
  • Exchange
  • TVTX Nasdaq
  • NUV Nasdaq
  • Market Cap
  • TVTX 1.7B
  • NUV 1.8B
  • IPO Year
  • TVTX N/A
  • NUV N/A
  • Fundamental
  • Price
  • TVTX $20.02
  • NUV $8.71
  • Analyst Decision
  • TVTX Strong Buy
  • NUV
  • Analyst Count
  • TVTX 14
  • NUV 0
  • Target Price
  • TVTX $33.31
  • NUV N/A
  • AVG Volume (30 Days)
  • TVTX 1.6M
  • NUV 464.9K
  • Earning Date
  • TVTX 05-01-2025
  • NUV 01-01-0001
  • Dividend Yield
  • TVTX N/A
  • NUV 3.96%
  • EPS Growth
  • TVTX N/A
  • NUV N/A
  • EPS
  • TVTX N/A
  • NUV N/A
  • Revenue
  • TVTX $273,533,000.00
  • NUV N/A
  • Revenue This Year
  • TVTX $68.31
  • NUV N/A
  • Revenue Next Year
  • TVTX $55.65
  • NUV N/A
  • P/E Ratio
  • TVTX N/A
  • NUV N/A
  • Revenue Growth
  • TVTX 75.65
  • NUV N/A
  • 52 Week Low
  • TVTX $6.01
  • NUV $7.86
  • 52 Week High
  • TVTX $25.29
  • NUV $9.08
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 58.32
  • NUV 55.91
  • Support Level
  • TVTX $19.65
  • NUV $8.60
  • Resistance Level
  • TVTX $22.07
  • NUV $8.74
  • Average True Range (ATR)
  • TVTX 1.11
  • NUV 0.07
  • MACD
  • TVTX 0.31
  • NUV 0.02
  • Stochastic Oscillator
  • TVTX 69.58
  • NUV 86.21

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About NUV Nuveen Municipal Value Fund Inc.

Nuveen Municipal Value Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax by investing in a portfolio of municipal obligations issued by state and local government authorities or certain U.S. territories.

Share on Social Networks: